Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johannes Lorscheider

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2025
Treating comorbidities in MS is disease modifying: NoJohannes Lorscheider
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 19, 2021
When does a heap become a heap?Johannes Lorscheider
Journal of Medical Case Reports|June 14, 2019
Hypothyroidism manifesting as multiple cranial neuropathies: a case reportMatthias Hepprich, Johannes Lorscheider, Nils Peters, et al.
Journal of Medical Internet Research|November 18, 2021
Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational StudyTim Woelfle, Silvan Pless, Andrea Wiencierz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2019
A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescenceMartin Diebold, Valerian Altersberger, Bernhard F Décard, et al.
Journal of Medical Internet Research|July 27, 2023
Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and PerspectiveTim Woelfle, Lucie Bourguignon, Johannes Lorscheider, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 4, 2020
Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PMLBettina Fischer-Barnicol, Johanna Oechtering, Jens Kuhle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 23, 2019
PML with dimethyl fumarate-No convincing case against natalizumabMartin Diebold, Valerian Altersberger, Bernhard F Décard, et al.
Multiple Sclerosis and Related Disorders|November 1, 2023
Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severityTim Woelfle, Silvan Pless, Óscar Reyes, et al.
Frontiers in Neurology|September 7, 2021
Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two CasesCharidimos Tsagkas, Maria Janina Wendebourg, Matthias Mehling, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 3, 2025
Treating comorbidities in MS is disease modifying: NoJohannes Lorscheider
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 19, 2021
When does a heap become a heap?Johannes Lorscheider
Journal of Medical Case Reports|June 14, 2019
Hypothyroidism manifesting as multiple cranial neuropathies: a case reportMatthias Hepprich, Johannes Lorscheider, Nils Peters, et al.
Journal of Medical Internet Research|November 18, 2021
Practice Effects of Mobile Tests of Cognition, Dexterity, and Mobility on Patients With Multiple Sclerosis: Data Analysis of a Smartphone-Based Observational StudyTim Woelfle, Silvan Pless, Andrea Wiencierz, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2019
A case of progressive multifocal leukoencephalopathy under dimethyl fumarate treatment without severe lymphopenia or immunosenescenceMartin Diebold, Valerian Altersberger, Bernhard F Décard, et al.
Journal of Medical Internet Research|July 27, 2023
Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and PerspectiveTim Woelfle, Lucie Bourguignon, Johannes Lorscheider, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 4, 2020
Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PMLBettina Fischer-Barnicol, Johanna Oechtering, Jens Kuhle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 23, 2019
PML with dimethyl fumarate-No convincing case against natalizumabMartin Diebold, Valerian Altersberger, Bernhard F Décard, et al.
Multiple Sclerosis and Related Disorders|November 1, 2023
Smartwatch-derived sleep and heart rate measures complement step counts in explaining established metrics of MS severityTim Woelfle, Silvan Pless, Óscar Reyes, et al.
Frontiers in Neurology|September 7, 2021
Acute Polyradiculomyelitis With Spinal Cord Gray Matter Lesions: A Report of Two CasesCharidimos Tsagkas, Maria Janina Wendebourg, Matthias Mehling, et al.
Pageof 5